NEW DELHI: India approached the launch of its Covid-19 vaccination plan with the drug regulator’s committee of subject matter experts on Friday recommending emergency use authorization (EUA) for the Serum Institute of India’s “Covishield” , developed by the University of Oxford and AstraZeneca. The sources said the SEC’s recommendations come …
Read More »Happy New Year: Expert Panel Approves Oxford Vaccine for India | India News
